| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.22 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |